John Cryan
8Patents
2h-index
23Co-inventors
47Inventor score
Filing activity: Feb 16, 2004 → Sep 4, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10144978B2 | Probiotic bifidobacterium strain | Emerging Cross-Sectional Technologies | 4 | Active |
| US10813366B2 | Bifidobacterium longum NCIMB 41676 | Chemistry; Metallurgy | 2 | Active |
| US11225641B2 | Probiotic Bifidobacterium strain | Emerging Cross-Sectional Technologies | 1 | Active |
| US11419902B2 | Compositions comprising bacterial strains | Emerging Cross-Sectional Technologies | 0 | Active |
| US11833178B2 | Bifidobacterium longum for treating obesity and weight management | Chemistry; Metallurgy | 0 | Active |
| US10597739B2 | Probiotic bifidobacterium strain | Emerging Cross-Sectional Technologies | 0 | Active |
| US11376284B2 | Compositions comprising bacterial strains | Chemistry; Metallurgy | 0 | Active |
| US7638510B2 | Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.